A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a ...

Hims & Hers said that existing patients will have the opportunity to transition to FDA-approved medicines when their providers deem it clinically appropriate. ・The company stated that Ozempic ...

Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...

Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side ...

New research has found that people taking medications such as Mounjaro or Wegovy for weight loss purposes may regain the majority of the weight they lost when they stop taking it. The jabs, also known ...

Novo Nordisk (NYSE:NVO)and US telehealth company Hims & Hers (NYSE:HIMS) have announced a collaboration that will bring the Danish drugmaker’s weight-loss medications Wegovy and Ozempic to Hims & Hers ...

People on weight loss jabs such as Mounjaro and Wegovy regain almost two thirds of the weight they lose within a year of stopping treatment, a study suggests ...

Ozempic is a popular injectable medication that has gained attention worldwide, especially for managing type 2 diabetes and aiding weight loss. Its active ingredient, semaglutide, belongs to a class ...

Your doctor will help you decide which form, pill or injection, of Wegovy is best for you. It may depend on your medical history, which dosing schedule fits your lifestyle better, and how comfortable ...